DONALDSON Co INC Q3 FY2025 earnings call

Management Statement and Operational Highlights

• Todd Carpenter noted the company delivered record sales and adjusted earnings, with earnings growth outpacing sales growth for seven quarters due to operating margin expansion. The company repurchased shares and announced an 11% increase in the quarterly dividend. Rich Lewis was appointed chief operating officer effective August 1st.
• Segment Highlights: Mobile Solutions saw growth in constant aftermarket business; Industrial Solutions had volume growth and pricing driving sales increase with profitability improving; Life Sciences operates with a leaner cost structure, and the Isolair Bio business announced availability of manufacturing-grade product.
• Tariff impact on net results was immaterial, and the company's operating model provides natural hedging from tariff impacts. The fiscal 2024 sustainability report was released, highlighting efforts like virtual power purchase agreement with PepsiCo.

Segment Performance

• Mobile Solutions: Total sales were $583 million, roughly flat with prior year. Aftermarket sales were $460 million, a 3% increase driven primarily by mid-single-digit growth in the OE channel; independent channel sales were up low single digits from market share gains. First fit businesses faced end market pressures: off-road sales were $96 million (-8%), on-road sales of $27 million declined 25%. Mobile Solutions China sales increased 27% from growth in both first fit and aftermarket.
• Industrial Solutions: Industrial sales rose 5% to $283 million. IFS sales were $232 million, a 1% increase from prior year. Aerospace and defense sales grew to a record $52 million largely from robust aerospace market demand.
• Life Sciences: Sales of $74 million grew 1% compared with prior year. Double-digit sales growth in disk drive and food and beverage replacement parts was partially offset by timing of bioprocessing sales.

Guidance

• Full-year total sales projected to increase between 1% and 3%. Pricing expected to contribute ~1%, currency translation and tariff impacts negligible.
• Mobile Solutions: Flat to up 2% sales; on-road first fit sales decline due to global truck production weakness; off-road sales mid-single-digit decline; aftermarket sales low single-digit increase.
• Industrial Solutions: Sales forecast to grow between 2% and 4%; IFS sales expected to increase low single digits with replacement part growth offsetting new equipment declines; aerospace and defense sales projected to increase in the low teens.
• Life Sciences: High single-digit growth expected. Full-year segment profitability roughly breakeven. Operating margin forecast between 15.6% and 16.0%. Adjusted EPS guidance $3.64 to $3.70, midpoint up $0.03 from prior guidance. Dividend increased 11%, share repurchase expected between 3.5% and 4%.

Risks

• Tariff uncertainties and their potential impact on demand disruption.
• Supply chain disruptions affecting execution of projects, especially in aerospace and defense.
• Bioprocessing market headwinds with elongated ramp-up in sales and profitability for upstream bioprocessing businesses (Univercells Technologies and Solaris).

Question and Answer

• Q: Tim Stein asked about fiscal 2026 outlook and mobile aftermarket inventory. A: Todd Carpenter said mobile aftermarket channels have comfortable inventory levels and company is poised to leverage economic upturn; fiscal 2026 plans to be shared in 90 days.
• Q: Adam Farley asked about tariff impact on demand disruption. A: Todd Carpenter said it's tough to predict, but aftermarket and service-based businesses continue to perform well while first fit projects are more cautious.